Clinical Trials Browser

Phase 1/2 × Hyperthermic Intraperitoneal Chemotherapy × 90 days × Clear all

NCT01226550 2025-12-19

Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan

Phase 1/2 Completed

Peritoneal Neoplasms